Open AccessAbility to successfully use an epinephrine auto‐injector after switching to a different device
Author(s) -
Boyle Robert,
Procktor Annabella,
Phillips Katherine,
Pinto Camila,
Hanna Heather,
Umasunthar Thisanayagam
Publication year - 2015
Publication title -
clinical and translational allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.979
H-Index - 37
ISSN - 2045-7022
DOI - 10.1186/2045-7022-5-s3-p5
Subject(s) - medicine , epinephrine , anaphylaxis , anesthesia , allergy , immunology
Methods We evaluated mothers of food-allergic children participating in a UK study of epinephrine auto-injectors (EAI), 1 year after they were first trained to use an EAI, either Anapen or Epipen (old design). Participants’ ability to deliver epinephrine using their device was assessed using a simulated anaphylaxis scenario. Participants then underwent repeat assessment using a different EAI device, randomly allocated, without training on the new device. The UK-approved EAIs Epipen (new/old designs), JEXT or Anapen were used, or Intelliject, an EAI with audio/visual prompts approved in North America as AuviQ(tm) and Allerject. ISRCTN29175528